| Water Retention | |
|---|---|
| Hepatotoxicity | |
| Lab Test | Monitoring levels is not typically required but may be done in specific cases |
| Strength | |
| Also known as | |
| Blood pressure | |
| Trade name | |
| Storage conditions | |
| Chemical name | |
| Formula | |
| Substance class | |
| Main action | Acts on synaptic vesicle protein SV2A, which modulates neurotransmitter release |
| Half-life | |
| Dosage (medical) | Typically starts at 500 mg twice daily, adjustable based on patient response and needs |
| Dosage (sports) | Not applicable, as it is not used to enhance athletic performance |
| Effects | |
| Side effects | May include dizziness, fatigue, drowsiness, irritability, and coordination difficulties |
| Use in sports | |
| Manufacturer |
Keppra 250 mg Pharmaceutical
£12.00